Literature DB >> 23422568

Enigmatic astatine.

D Scott Wilbur1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422568     DOI: 10.1038/nchem.1580

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


× No keyword cloud information.
  3 in total

1.  British universities and secret theses for degrees.

Authors:  J E KEYSTONE
Journal:  Nature       Date:  1947-01-04       Impact factor: 49.962

Review 2.  Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.

Authors:  D Scott Wilbur
Journal:  Curr Radiopharm       Date:  2011-07

Review 3.  Astatine-211: production and availability.

Authors:  Michael R Zalutsky; Marek Pruszynski
Journal:  Curr Radiopharm       Date:  2011-07
  3 in total
  10 in total

1.  Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts.

Authors:  François Guérard; Yong-Sok Lee; Kwamena Baidoo; Jean-François Gestin; Martin W Brechbiel
Journal:  Chemistry       Date:  2016-06-15       Impact factor: 5.236

2.  Rapid Cu-Catalyzed [211At]Astatination and [125I]Iodination of Boronic Esters at Room Temperature.

Authors:  Sean W Reilly; Mehran Makvandi; Kuiying Xu; Robert H Mach
Journal:  Org Lett       Date:  2018-03-21       Impact factor: 6.005

3.  Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide.

Authors:  Kazunobu Ohnuki; Mitsuyoshi Yoshimoto; Hiromitsu Haba; Shino Manabe; Hiroki Takashima; Masahiro Yasunaga; Yasumasa Takenaka; Hirofumi Fujii
Journal:  EJNMMI Phys       Date:  2022-06-06

4.  Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.

Authors:  F Guérard; L Navarro; Y-S Lee; A Roumesy; C Alliot; M Chérel; M W Brechbiel; J-F Gestin
Journal:  Bioorg Med Chem       Date:  2017-09-19       Impact factor: 3.641

5.  Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.

Authors:  Emma Aneheim; Per Albertsson; Tom Bäck; Holger Jensen; Stig Palm; Sture Lindegren
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

6.  Folate receptor targeted alpha-therapy using terbium-149.

Authors:  Cristina Müller; Josefine Reber; Stephanie Haller; Holger Dorrer; Ulli Köster; Karl Johnston; Konstantin Zhernosekov; Andreas Türler; Roger Schibli
Journal:  Pharmaceuticals (Basel)       Date:  2014-03-13

7.  Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking.

Authors:  Christoph Denk; Martin Wilkovitsch; Emma Aneheim; Matthias M Herth; Holger Jensen; Sture Lindegren; Hannes Mikula
Journal:  Chempluschem       Date:  2019-04-04       Impact factor: 2.863

Review 8.  Production, purification and availability of 211At: Near term steps towards global access.

Authors:  Yutian Feng; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2021-06-10       Impact factor: 2.947

9.  Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.

Authors:  David Teze; Dumitru-Claudiu Sergentu; Valentina Kalichuk; Jacques Barbet; David Deniaud; Nicolas Galland; Rémi Maurice; Gilles Montavon
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

10.  The electron affinity of astatine.

Authors:  David Leimbach; Julia Karls; Yangyang Guo; Rizwan Ahmed; Jochen Ballof; Lars Bengtsson; Ferran Boix Pamies; Anastasia Borschevsky; Katerina Chrysalidis; Ephraim Eliav; Dmitry Fedorov; Valentin Fedosseev; Oliver Forstner; Nicolas Galland; Ronald Fernando Garcia Ruiz; Camilo Granados; Reinhard Heinke; Karl Johnston; Agota Koszorus; Ulli Köster; Moa K Kristiansson; Yuan Liu; Bruce Marsh; Pavel Molkanov; Lukáš F Pašteka; João Pedro Ramos; Eric Renault; Mikael Reponen; Annie Ringvall-Moberg; Ralf Erik Rossel; Dominik Studer; Adam Vernon; Jessica Warbinek; Jakob Welander; Klaus Wendt; Shane Wilkins; Dag Hanstorp; Sebastian Rothe
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.